Pnina Fishman
Founder bei CAN-FITE BIOPHARMA LTD.
Vermögen: 2 013 $ am 31.03.2024
Profil
Pnina Fishman is the founder of Can-Fite BioPharma Ltd., which was founded in 1994.
She currently holds the position of Executive Chairman & Chief Scientific Officer at Can-Fite BioPharma Ltd.
Dr. Fishman is also currently serving as a Director at Eyefite Ltd., Consulting F.D.
International Marketing & Engingeering Ltd., Ultratrend Ltd., and Fd Consulting Ltd.
In the past, she served as the Chief Executive Officer at Mor Research Applications Ltd.
and as the Chairman at OphthaliX, Inc. from 2013 to 2014.
Dr. Fishman also held the title of Professor at Rabin Medical Center Beilinson.
She obtained a doctorate degree from Bar-Ilan University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CAN-FITE BIOPHARMA LTD.
0,02% | 28.03.2024 | 263 433 ( 0,02% ) | 2 013 $ | 31.03.2024 |
Aktive Positionen von Pnina Fishman
| Unternehmen | Position | Beginn |
|---|---|---|
| CAN-FITE BIOPHARMA LTD. | Founder | 11.09.1994 |
| Consulting F.D. International Marketing & Engingeering Ltd. | Director/Board Member | - |
Eyefite Ltd.
 Eyefite Ltd. BiotechnologyHealth Technology Eyefite Ltd. provides ophthalmology research and develops pharmaceutical products. The company is headquartered in Ramat Gan, Israel. | Director/Board Member | - |
| Ultratrend Ltd. | Director/Board Member | - |
| Fd Consulting Ltd. | Director/Board Member | - |
Ehemalige bekannte Positionen von Pnina Fishman
| Unternehmen | Position | Ende |
|---|---|---|
Rabin Medical Center Beilinson
 Rabin Medical Center Beilinson Hospital/Nursing ManagementHealth Services Rabin Medical Center Beilinson provides hospital medical services. The private company is based in Petach Tikva, Israel. The CEO of the Israeli company is Eyran Halpern. | Corporate Officer/Principal | - |
| Mor Research Applications Ltd. | Chief Executive Officer | - |
OphthaliX, Inc.
 OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel. | Chief Executive Officer | - |
Ausbildung von Pnina Fishman
| Bar-Ilan University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CAN-FITE BIOPHARMA LTD. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
OphthaliX, Inc.
OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel. | Health Technology |
| Mor Research Applications Ltd. | |
Rabin Medical Center Beilinson
Rabin Medical Center Beilinson Hospital/Nursing ManagementHealth Services Rabin Medical Center Beilinson provides hospital medical services. The private company is based in Petach Tikva, Israel. The CEO of the Israeli company is Eyran Halpern. | Health Services |
Eyefite Ltd.
Eyefite Ltd. BiotechnologyHealth Technology Eyefite Ltd. provides ophthalmology research and develops pharmaceutical products. The company is headquartered in Ramat Gan, Israel. | Health Technology |
| Consulting F.D. International Marketing & Engingeering Ltd. | |
| Ultratrend Ltd. | |
| Fd Consulting Ltd. |
